about
Personalized medicine and treatment approaches in hypertension: current perspectivesArm position during ambulatory blood pressure monitoring: a review of the evidence and clinical guidelinesData quality of an electronic health record tool to support VA cardiac catheterization laboratory quality improvement: the VA Clinical Assessment, Reporting, and Tracking System for Cath Labs (CART) program.Pollen count and presentation of angiotensin-converting enzyme inhibitor-associated angioedema.Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedemaAnxiety in the "age of hypertension".Combination therapy as initial treatment for newly diagnosed hypertension.Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant useSerum Cortisol-to-Cortisone Ratio and Blood Pressure in Severe Obesity before and after Weight Loss.Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibitionGenetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema.A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension.The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertension.Discordance between Imaging and Immunohistochemistry in Unilateral Primary Aldosteronism.Reach Out Churches: A Community-Based Participatory Research Pilot Trial to Assess the Feasibility of a Mobile Health Technology Intervention to Reduce Blood Pressure Among African Americans.EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research.Acute increase in blood pressure during inhalation of coarse particulate matter air pollution from an urban location.Aldosterone Synthase Promoter Polymorphism and Cardiovascular Phenotypes in a Large, Multiethnic Population-Based Study.Data-Sharing Models.Detection and recognition of hypertension in anxious and depressed patients.Clopidogrel prescription filling delays and cardiovascular outcomes in a pharmacy system integrating inpatient and outpatient care: insights from the Veterans Affairs CART Program.The possibility of unmeasured confounding variables in observational studies: a forgotten fact?Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema.Use of physician-recommended non-pharmacological strategies for hypertension control among hypertensive patients.Cigarette Smoking and Subtypes of Uncontrolled Blood Pressure Among Diagnosed Hypertensive Patients: Paradoxical Associations and Implications.Opening Opportunities With Open Data.Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017.Human Urinary mRNA as a Biomarker of Cardiovascular DiseasePrimary AldosteronismPrivacy-preserving generative deep neural networks support clinical data sharingMonitoring Blood Pressure Outside of the Doctor's OfficeOut-of-Office Blood Pressure Monitoring in 2018Clinical research using extracellular vesicles: insights from the International Society for Extracellular Vesicles 2018 Annual MeetingMinimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelinesPRIMARY ALDOSTERONISM IN THE PRIMARY CARE CLINIC: RIFE OR RARE?Resistance to recommending exercise in hypertension?Pericardial Effusion in Renal Disease: To Tap or Not to TapDipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor–induced peritracheal edemaAngiotensin Receptor Blockers and the Risk of Cancer: Insights from Clinical Trials and Recent Drug RecallsSound Science before Quick Judgement Regarding RAS Blockade in COVID-19
P50
Q26751135-FFB54CAC-B3A5-4F62-887F-5BFCDB42AC04Q26851169-0515A59D-5905-4B41-A421-D0DD15D39B97Q30596387-753F749A-4D4B-4D78-93D9-67E35CC46A73Q33702327-016DE1C0-946C-4130-8F8F-AB146CC60A61Q34153767-A260EB57-78F5-40C0-AA39-BFE932DE17BEQ34435575-59870418-9925-447E-B360-5599DA4B3D97Q35156143-56D7A2AE-792B-47B6-A882-2DF05EB5D65BQ35833722-BA035978-F58A-4C06-B28A-3F14767197C6Q36423063-791211E9-7258-4515-9D6E-7EF5A6DF2682Q36968558-1CBFF401-FA4E-4DAB-8E65-F323109AC1DDQ37524447-65D0B301-4C18-44A0-AEB2-FCB8E22D97C0Q38108677-D6323254-B680-4D0D-8465-9BC60D73D48DQ38182880-FA88553D-8969-4710-84CA-AF05FCD81BF2Q38634514-6235EF6B-3986-4015-85B9-9DFDD5ABB906Q38674584-EFCF525A-6288-41CE-B454-51E772CAF928Q40314364-982F132E-F0E5-4709-8764-9C5FC3DFA776Q40343218-0CB56AC1-A3CF-4124-989E-9793AD1071E7Q41496058-73D3A7FD-68D1-4B53-9181-7349EBB7BE7BQ42670436-03FF0EA4-6B11-491B-9DD0-9E52A7670F56Q44493099-556AE159-8034-461E-818B-134D9235BF76Q45328680-7CFBEE1F-2D12-4287-A2A7-61468401E31FQ45851544-81347915-55DA-45FE-8B3D-DFFD8C5098EFQ47616771-A4812511-2BDF-4189-BD64-CA0275EBE0A9Q49944784-C62B8AF6-886C-4E41-A069-6A551E1E7107Q53658466-4BEFA1BF-46B9-4FA6-B025-E55CF3BD65C4Q53830200-6E6FCE7F-CE9D-4EA2-AA42-AE98FA57E949Q55007412-EBE2F02F-98A5-4CC4-80AE-D99A4E589023Q57822682-8C5942AE-6B9B-459B-BBAA-563A0FA42E19Q57823676-E49CEC3C-F640-4D8E-BB15-4B3D1D449E68Q57897468-D7BDB59E-E97F-4120-AE4A-96B8E55AB68FQ58607817-E2F841B9-5684-4936-8056-14FF367B94EEQ58607838-A6DCDA50-E824-48AC-BD76-818D23AEAECBQ58708099-8BD8F5BB-3436-4D52-A22E-958BEDFE7812Q60326168-31769425-CF47-4180-B119-613A801FADC9Q61799423-A62D8BF8-08BC-4F0D-8FCF-3633CA2D8BA2Q61799439-2BE5A616-7C39-424D-A2D0-6871FD186DF4Q61799485-448FC125-2495-49E7-8B2B-D2FE56FE64DCQ61799508-62F71AE0-E831-455C-9793-098DB786E855Q89957914-F845C2D7-AF4C-461F-86CB-F227388D57BCQ90711199-35B4FE7E-38AC-4F95-95F7-CDC263A56EAA
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
James Brian Byrd
@ast
James Brian Byrd
@en
James Brian Byrd
@es
James Brian Byrd
@nl
James Brian Byrd
@sl
type
label
James Brian Byrd
@ast
James Brian Byrd
@en
James Brian Byrd
@es
James Brian Byrd
@nl
James Brian Byrd
@sl
altLabel
Brian Byrd
@en
James Brian Byrd
@en
James Byrd
@en
prefLabel
James Brian Byrd
@ast
James Brian Byrd
@en
James Brian Byrd
@es
James Brian Byrd
@nl
James Brian Byrd
@sl
P106
P21
P31
P496
0000-0002-0509-3520